SCC tissues; adjacent non-tumorous tissues; tumor tissues
ECT1/E6E7; SiHa; SW756
cell line-derived xenograft
proliferation (promotes); cell cycle (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); glycolysis (promotes); ceRNA regulation (promotes); other pathway/process (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; MTT; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Transwell Assay; Western Blot; In Vivo Animal Model; Survival Analysis; Bioinformatics Analysis
High circSOS2 expression was associated with poor overall survival, low differentiation, positive vascoinvasion, and potential prognostic value in SCC.
CircSOS2 is up-regulated in human cervical squamous cell carcinoma tissues and cells and high expression predicts poor overall survival. Functionally, circSOS2 promotes SCC cell proliferation, cell cycle progression, migration, invasion, glycolysis, and in vivo tumor growth while suppressing apoptosis. Mechanistically, it acts through the miR-543/FNDC3B axis.
0.8689
CircSOS2 promotes cervical squamous cell carcinoma by regulation of proliferation, cell cycle, apoptosis, migration, invasion, and glycolysis by targeting miR-543/FNDC3B axis.
combined biological and clinical study